All In Biotech

Free tool

FAERS Monitor: Nuvaring

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021187 or its brand name (Nuvaring, Ethinyl Estradiol, Etonogestrel). Reports on generic versions are filed under their own applications.

Reports

21,475

Serious

10,461

49% of reports

Hospitalization

6,033

Death reported

280

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • pulmonary embolism3,951
  • deep vein thrombosis2,659
  • inappropriate schedule of drug administration2,229
  • device expulsion1,366
  • no adverse event1,204
  • headache1,151
  • metrorrhagia1,132
  • incorrect drug administration duration1,017
  • nausea1,012
  • unintended pregnancy956
  • depression910
  • anxiety862
  • migraine801
  • off label use726
  • menorrhagia625

Reports by year received

View as table
YearReports
20041,304
2005130
2006255
2007173
2008190
2009483
2010678
20111,020
20121,697
20132,982
20143,782
20151,561
20161,659
20171,512
20181,184
2019747
2020690
2021347
2022315
2023186
2024184
2025164
2026232

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,032,684 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
unintended pregnancySignal95698.592.383,799
metrorrhagiaSignal1,13269.665.671,418
pulmonary embolismSignal3,95142.441.2153,888
deep vein thrombosisSignal2,65941.740.2101,693
incorrect drug administration durationSignal1,01736.734.534,055
menorrhagiaSignal62532.229.718,258
inappropriate schedule of drug administrationSignal2,22931.630.464,271
device expulsionSignal1,36621.120.025,600
migraineSignal8018.37.75,099
no adverse eventSignal1,2046.56.25,662
depressionSignal9103.93.71,998
anxietySignal8623.02.81,138
headache1,1511.81.7420
nausea1,0121.31.253
off label use7260.80.833

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.